Recruiting studies: Large Vessel Vasculitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arterit
Phase N/A · 1 location(s) · University Hospital, Basel, Switzerland · NCT05479448 Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)
Phase 2 · 1 location(s) · University of Edinburgh · NCT06887062 A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis
Phase 2 · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06335888 Biologic Treatment Withdrawal in Takayasu Arteritis Patients in Sustained Remission
NA · 1 location(s) · Marmara University · NCT07491913 Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168 Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis
Phase N/A · 1 location(s) · Guang'anmen Hospital of China Academy of Chinese Medical Sci · NCT07301892 AYLo - AutoimmunitY and Loss of y
Phase N/A · 1 location(s) · University of Bonn · NCT06696027 Prediction of Risk of Vascular Structural Damage in Patients With Large Vessel Vasculitis (LVV) Based on PET/MRA Image E
Phase N/A · 1 location(s) · Nanjing Medical University · NCT06824714

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.